Results for Lentivirus ( 657 )
- From: €1,154.00
Please note this product may be subject to fees, we invite you to contact your local office. The FcRL5 Lentiviruses are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to transduce nearly all types of mammalian cells, including primary and non-dividing cells. The particles contain a human FcRL5 (NM_031281.3) driven by an EF1A promoter and a puromycin selection marker (Figure 1). <img style="display: block; margin-left: auto; margin-right: auto;" src="{{media url="wysiwyg/Lentivirus/78715.png"}}" alt="" width="364" height="329" /> Figure 1: Schematic of the lenti-vector used to generate the FcRL5 Lentivirus.
- From: €1,086.00
The GPRC5D Lentiviruses are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to transduce nearly all types of mammalian cells, including primary and non-dividing cells. The particles contain a human GPRC5D (NM_018654.1) driven by a CMV promoter and a Hygromycin selection marker (Figure 1). <img style="display: block; margin-left: auto; margin-right: auto;" src="{{media url="wysiwyg/Imtx/78716.png"}}" alt="" width="340" height="307" /> Figure 1: Schematic of the lenti-vector used to generate the GPRC5D Lentivirus
- From: €913.00
Please note this product may be subject to fees, we invite you to contact your local office. The NKp46 Lentiviruses are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to transduce nearly all types of mammalian cells, including primary and non-dividing cells. The particles contain a human NKp46 (NM_004829.7) driven by an EF1A promoter and a puromycin selection marker (Figure 1). <img style="display: block; margin-left: auto; margin-right: auto;" src="{{media url="wysiwyg/Lentivirus/78717.png"}}" alt="" width="391" height="353" /> Figure 1: Schematic of the lenti-vector used to generate the NKp46 Lentivirus.
- From: €1,143.00
Please note this product may be subject to fees, we invite you to contact your local office. The EpCAM Lentiviruses are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to transduce nearly all types of mammalian cells, including primary and non-dividing cells. The particles contain a human EpCAM (NM_002354.3) driven by an EF1A promoter and a puromycin selection marker (Figure 1). <img src="{{media url="wysiwyg/Lentivirus/78718.png"}}" alt="" width="446" height="363" /> Figure 1: Schematic of the lenti-vector used to generate the EpCAM Lentivirus
- From: €1,086.00
The CEACAM5 Lentiviruses are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to transduce nearly all types of mammalian cells, including primary and non-dividing cells. The particles contain a human CEACAM5 (NM_004363.6) driven by an EF1A promoter and a puromycin selection marker (Figure 1). <img src="{{media url="wysiwyg/Imtx/78719.png"}}" alt="" width="348" height="310" /> Figure 1: Schematic of the lenti-vector used to generate the CEACAM5 Lentivirus
- From: €1,140.00
The CEACAM6 Lentiviruses are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to transduce nearly all types of mammalian cells, including primary and non-dividing cells. The particles contain a human CEACAM6 (NM_002483.7) driven by an EF1A promoter and a puromycin selection marker (Figure 1). <img style="display: block; margin-left: auto; margin-right: auto;" src="{{media url="wysiwyg/Imtx/78720.png"}}" alt="" width="426" height="347" /> Figure 1: Schematic of the lenti-vector used to generate the CEACAM6 Lentivirus
- From: €913.00
Please note this product may be subject to fees, we invite you to contact your local office. The LYPD1 Lentiviruses are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to transduce nearly all types of mammalian cells, including primary and non-dividing cells. The particles contain a human LYPD1 (NM_ 001321234.2) driven by a EF1A promoter and a puromycin selection marker (Figure 1). <img style="display: block; margin-left: auto; margin-right: auto;" src="{{media url="wysiwyg/Lentivirus/78724.png"}}" alt="" width="450" height="364" /> Figure 1: Schematic of the lenti-vector used to generate the LYPD1 Lentivirus
- From: €1,359.00
The PSMA Lentiviruses are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to transduce nearly all types of mammalian cells, including primary and non-dividing cells. The particles contain a human PSMA (NM_ 004476.3) driven by a CMV promoter and a puromycin selection marker (Figure 1). <img src="{{media url="wysiwyg/Imtx/78726.png"}}" alt="" width="352" height="313" /> Figure 1: Schematic of the lenti-vector used to generate the PSMA Lentivirus.
- From: €1,086.00
The B7-H4 Lentiviruses are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to transduce nearly all types of mammalian cells, including primary and non-dividing cells. The particles contain a human B7-H4 (NM_ 024626.4) driven by a CMV promoter and a puromycin selection marker (Figure 1). <img style="display: block; margin-left: auto; margin-right: auto;" src="{{media url="wysiwyg/Imtx/78727.png"}}" alt="" width="406" height="361" /> Figure 1: Schematic of the lenti-vector used to generate the B7-H4 Lentivirus.